| Literature DB >> 18403639 |
Marie Bénéteau1, Mathieu Pizon, Benjamin Chaigne-Delalande, Sophie Daburon, Patrick Moreau, Francesca De Giorgi, François Ichas, Amélie Rebillard, Marie-Thérèse Dimanche-Boitrel, Jean-Luc Taupin, Jean-François Moreau, Patrick Legembre.
Abstract
Activation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway is known to protect tumor cells from apoptosis and more specifically from the Fas-mediated apoptotic signal. The antitumoral agent edelfosine sensitizes leukemic cells to death by inducing the redistribution of the apoptotic receptor Fas into plasma membrane subdomains called lipid rafts. Herein, we show that inhibition of the PI3K signal by edelfosine triggers a Fas-mediated apoptotic signal independently of the Fas/FasL interaction. Furthermore, similarly to edelfosine, blockade of the PI3K activity, using specific inhibitors LY294002 and wortmannin, leads to the clustering of Fas whose supramolecular complex is colocalized within the lipid rafts. These findings indicate that the antitumoral agent edelfosine down-modulates the PI3K signal to sensitize tumor cells to death through the redistribution of Fas into large platform of membrane rafts.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18403639 DOI: 10.1158/1541-7786.MCR-07-0331
Source DB: PubMed Journal: Mol Cancer Res ISSN: 1541-7786 Impact factor: 5.852